financetom
PLMR
financetom
/
Financials
/
PLMR
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Palomar Holdings, Inc.PLMR
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

Palomar Holdings, Inc., an insurance holding company, provides property and casualty insurance to residential and businesses in the United States.

The company offers personal and commercial specialty property insurance products, including residential and commercial earthquake, fronting, commercial all risk, specialty homeowners, inland marine, Hawaii hurricane, and residential flood, as well as other products, such as assumed reinsurance.

It markets and distributes its products through retail agents, wholesale brokers, program administrators, and carrier partnerships.

The company was formerly known as GC Palomar Holdings and changed its name to Palomar Holdings, Inc. The company was incorporated in 2013 and is headquartered in La Jolla, California.

Latest News >
Boeing on track to be 2024's biggest loser in Dow Jones Index
Boeing on track to be 2024's biggest loser in Dow Jones Index
Dec 31, 2024
(Reuters) - U.S. planemaker Boeing ( BA ) is on track to be the biggest loser of 2024 in the Dow Jones Index, tumbling 32% as it bounced from one crisis to another.  Rival Airbus rose more than 11% for the year, and the benchmark S&P 500 gained more than 23% during 2024.  Boeing's ( BA ) shares opened the...
Legacy Housing Insider Sold Shares Worth $425,099, According to a Recent SEC Filing
Legacy Housing Insider Sold Shares Worth $425,099, According to a Recent SEC Filing
Dec 31, 2024
02:11 PM EST, 12/31/2024 (MT Newswires) -- Curtis Drew Hodgson, 10% Owner, Director, on December 30, 2024, sold 17,300 shares in Legacy Housing ( LEGH ) for $425,099. Following the Form 4 filing with the SEC, Hodgson has control over a total of 4,173,778 shares of the company, with 404,722 shares held directly and 3,769,056 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1436208/000110465924132810/xslF345X05/tm2432358-1_4seq1.xml...
Update: ADC Shares Rise After Company Completes Enrollment in Late-Stage Zynlonta Combination Trial
Update: ADC Shares Rise After Company Completes Enrollment in Late-Stage Zynlonta Combination Trial
Dec 31, 2024
02:15 PM EST, 12/31/2024 (MT Newswires) -- (Updates with stock price movement in the headline and first paragraph) ADC Therapeutics ( ADCT ) gained as much as 4.2% in intraday trading Tuesday after the company said it had completed patient enrollment in its phase 3 confirmatory trial of Zynlonta in combination with rituximab in patients with relapsed or refractory diffuse...
Ultragenyx Pharmaceutical Insider Sold Shares Worth $495,231, According to a Recent SEC Filing
Ultragenyx Pharmaceutical Insider Sold Shares Worth $495,231, According to a Recent SEC Filing
Dec 31, 2024
02:11 PM EST, 12/31/2024 (MT Newswires) -- Emil D Kakkis, Director, President & CEO, on December 30, 2024, sold 11,727 shares in Ultragenyx Pharmaceutical ( RARE ) for $495,231. Following the Form 4 filing with the SEC, Kakkis has control over a total of 2,748,590 shares of the company, with 564,605 shares held directly and 2,183,985 controlled indirectly. SEC Filing:...
Copyright 2023-2025 - www.financetom.com All Rights Reserved